Confined copper depletion via a hydrogel platform for reversing dabrafenib/cetuximab resistance in BRAFV600E-mutant colorectal cancer
Journal of Controlled Release · 2024-11 · 375 · 643-653
DOI: 10.1016/j.jconrel.2024.09.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-11. Verfasst von Jue Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Proto-Oncogene Proteins B-raf, Oximes, Cetuximab. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Shanghai Rising-Star Program, National Key Research and Development Program of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, Chin…
- State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Electronic address: dg_wang@sjtu.edu.cn.
Förderung
- Shanghai Rising-Star Program
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Sun, X., Zhao, Z., Wang, G., Wang, D., & Li, Y. (2024). Confined copper depletion via a hydrogel platform for reversing dabrafenib/cetuximab resistance in BRAFV600E-mutant colorectal cancer. Journal of Controlled Release, 375, 643-653. https://doi.org/10.1016/j.jconrel.2024.09.034
Vancouver
Wang J, Sun X, Zhao Z, Wang G, Wang D, Li Y. Confined copper depletion via a hydrogel platform for reversing dabrafenib/cetuximab resistance in BRAFV600E-mutant colorectal cancer. Journal of Controlled Release. 2024;375:643-653. doi:10.1016/j.jconrel.2024.09.034
BibTeX
@article{Wang2024,
author = {Wang, Jue and Sun, Xiangshi and Zhao, Zhiwen and Wang, Guanru and Wang, Dangge and Li, Yaping},
title = {Confined copper depletion via a hydrogel platform for reversing dabrafenib/cetuximab resistance in BRAFV600E-mutant colorectal cancer},
journal = {Journal of Controlled Release},
year = {2024},
volume = {375},
pages = {643--653},
doi = {10.1016/j.jconrel.2024.09.034}
}
EUVIMED